HealthQuill Tuberculosis
Cepheid Inc., a US molecular diagnostics company and a wholly-owned arm of Danaher Corporation has been granted WHO prequalification for its diagnostic tests for tuberculosis.
Uncategorized

Danaher’s Cepheid gets first WHO prequalification nod for TB tests

Cepheid Inc., a US molecular diagnostics company and a wholly-owned arm of Danaher Corporation has been granted WHO prequalification for its diagnostic tests.

Read More
Malaria, HIV, and tuberculosis were among a list of 17 disease-causing pathogens where vaccines need to be developed as a priority to reduce regional disease burden, according to the World Health Organization.
Drugs Health Pharma

Malaria, TB among top diseases where vaccines needed most: WHO 

Malaria, HIV, and tuberculosis were among a list of 17 disease-causing pathogens where vaccines need to be developed as a priority to reduce.

Read More
Tuberculosis has emerged as the world’s top infectious disease with about 8.2 million people newly diagnosed with the illness last year — the highest on records since WHO began global monitoring in 1995.
Drugs Health Medical

Tuberculosis was the world’s top infectious disease killer last year

Tuberculosis has emerged as the world’s top infectious disease with about 8.2 million people newly diagnosed with the illness last year — the.

Read More
the BCG vaccine does not provide consistent and optimal protection against TB there is an urgent need for a more effective vaccine.
Drugs Health Opinion Pharma

Opinion: Time to explore a new vaccine, booster for tuberculosis

By K Leelamoni April 30, 2024: Tuberculosis (TB) is the world’s leading cause of death from a single infectious agent — next to.

Read More
The first dosing in a late-stage trial to evaluate an investigational drug for tuberculosis (TB) has started in South Africa, which has one of the highest burdens in the world.
Drugs Health Pharma

First late-stage trial vaccine doses begin in South Africa for tuberculosis

 HQ Team March 20, 2024: The first dosing in a late-stage trial to evaluate an investigational drug for tuberculosis (TB) has started in.

Read More
Last year about 7.5 million people had tuberculosis (TB), the world’s second-most infectious killer, and multi-drug resistant form of the disease remains a health crisis, the WHO stated.
Drugs Health Pharma

Globally, 7.5 million people got tuberculosis last year: WHO report

Last year about 7.5 million people had tuberculosis (TB), the world’s second-most infectious killer, and multi-drug resistant form of the disease remains a.

Read More
The WHO’s rapid test will be used as the first method to diagnose tuberculosis and the global health agency will license one TB vaccine in a bid to reach 90% of the patients and to end the epidemic.
Drugs Health Pharma

WHO sets up body to develop, licence a new vaccine to fight tuberculosis

HQ Team September 23, 2023: The WHO’s rapid test will be used as the first method to diagnose tuberculosis and the global health.

Read More
Drugs Medical Pharma

Wellcome, Bill & Melinda invest $550 million for new TB vaccine

HQ Team June 30, 2023: Two philanthropic health majors, Wellcome and the Bill & Melinda Gates Foundation, have come together to invest around.

Read More
Peptide drug conjugate
Health Pharma

Tuberculosis claims 1.6 million people in 2021, WHO says

Tuberculosis, the second deadliest infectious killer after Covid-19, claimed 1.6 million lives last year, including 187,000 HIV-positive patients, according to the WHO's 2022.

Read More